Home/Filings/4/0001728117-25-000012
4//SEC Filing

Aranda Richard 4

Accession 0001728117-25-000012

CIK 0001728117other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:05 PM ET

Size

5.5 KB

Accession

0001728117-25-000012

Insider Transaction Report

Form 4
Period: 2025-03-04
Aranda Richard
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-04+572,000572,000 total
    Exercise: $1.13Exp: 2035-03-03Common Stock (572,000 underlying)
Footnotes (1)
  • [F1]25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001867872

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:05 PM ET
Size
5.5 KB